NEW YORK (GenomeWeb) – Advanced Biological Laboratories and the HIV Resistance Response Database Initiative (RDI) this week announced a collaboration on HIV management.

Under the agreement, data stored in ABL's health management system, TherapyEdge, can be automatically uploaded to RDI's HIV Treatment Response Prediction System (HIV-TRePS), allowing physicians to predict patient response to HIV drug combinations in seconds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.